$30.79
-1.10-3.45%
At close: -
$30.79
0.000.00%
After Hours: 4:00 PM EDT
Astrana Health reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Astrana Health using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ASTH | Astrana Health | $0.31 | $0.41 | — | — | $404.36M | $617.96M | — | — | 05/06/2025 | Get Alert |
ASTH | Astrana Health | $0.26 | $0.24 | -$0.15 | -162.50% | $353.04M | $617.24M | $665.21M | 7.77% | 02/27/2025 | Get Alert |
ASTH | Astrana Health | $0.47 | $0.32 | $0.33 | 3.12% | $348.17M | $462.37M | $478.71M | 3.53% | 11/07/2024 | Get Alert |
ASTH | Astrana Health | $0.28 | $0.39 | $0.40 | 2.56% | $348.21M | $436.74M | $486.26M | 11.34% | 08/07/2024 | Get Alert |
ASTH | Astrana Health | $0.28 | $0.30 | $0.31 | 3.33% | $337.24M | $412.56M | $404.36M | -1.99% | 05/07/2024 | Get Alert |
ASTH | Astrana Health | -$0.08 | — | $0.26 | — | $294.21M | — | $353.04M | — | 02/27/2024 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-27 | $-0.15 | $0.24 | -162.5 % |
Q3 | 2024-11-07 | $0.33 | $0.32 | 3.12 % |
Q2 | 2024-08-07 | $0.40 | $0.39 | 2.56 % |
Q1 | 2024-05-07 | $0.31 | $0.30 | 3.33 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-27 | $665.21M | $617.24M | 7.77 % |
Q3 | 2024-11-07 | $478.71M | $462.37M | 3.53 % |
Q2 | 2024-08-07 | $486.27M | $436.74M | 11.3 % |
Q1 | 2024-05-07 | $404.36M | $412.56M | -1.99 % |
Astrana Health (ASTH) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
The Actual EPS was $-0.15, which missed the estimate of $0.24.
The Actual Revenue was $665.2M, which beat the estimate of $617.2M.
Browse earnings estimates, EPS, and revenue on all stocks.